Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Taiko Pharmaceutical Co Ltd
TSE:4574

Watchlist Manager
Taiko Pharmaceutical Co Ltd Logo
Taiko Pharmaceutical Co Ltd
TSE:4574
Watchlist
Price: 301 JPY 0.33% Market Closed
Market Cap: ¥15.2B
Write Note Create Alert Ask AI
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Cash Flow Statement

Operating Cash Flow
+
3Y
-
5Y
-
10Y
-
Investing Cash Flow
+
3Y
-25%
5Y
-
10Y
-
Financing Cash Flow
+
3Y
-23%
5Y
-89%
10Y
-

Cash Flow Statement
Taiko Pharmaceutical Co Ltd

Rotate your device to view
Cash Flow Statement
Currency: JPY
Dec-2009 Jun-2010 Sep-2010 Dec-2010 Mar-2011 Sep-2011 Mar-2012 Sep-2012 Mar-2013 Sep-2013 Mar-2014 Sep-2014 Mar-2015 Sep-2015 Mar-2016 Sep-2016 Mar-2017 Sep-2017 Mar-2018 Sep-2018 Mar-2019 Sep-2019 Mar-2020 Sep-2020 Dec-2020 Jun-2021 Dec-2021 Jun-2022 Dec-2022 Jun-2023 Dec-2023 Jun-2024 Dec-2024 Jun-2025 Dec-2025
Operating Cash Flow
Net Income
3 096
(966)
(1 162)
(3 632)
(1 996)
(1 151)
415
556
1 101
2 007
2 554
2 181
2 759
1 882
1 192
1 338
1 491
1 543
1 553
1 766
1 986
2 254
3 504
6 734
5 374
2 473
(8 887)
(8 779)
(4 869)
(2 568)
(3 563)
(2 347)
565
223
958
Depreciation & Amortization
202
11
69
26
241
251
259
254
251
255
259
264
281
277
351
444
445
450
454
451
461
480
495
525
473
927
941
859
737
716
704
481
256
253
265
Other Non-Cash Items
77
(91)
24
(5)
748
686
392
53
(58)
43
193
(196)
(726)
(237)
(56)
(69)
116
(22)
157
82
(162)
(198)
339
333
(286)
(572)
2 972
2 474
(33)
150
2 348
2 672
150
(91)
(392)
Cash Taxes Paid
328
640
643
495
850
37
13
13
13
101
127
921
1 075
816
652
240
359
465
567
528
566
655
724
1 203
1 420
2 438
1 030
16
23
22
0
4
30
40
34
Cash Interest Paid
0
0
0
0
0
0
0
0
0
0
0
0
0
1
3
0
0
0
0
0
0
0
0
0
0
2
6
10
10
8
8
8
8
7
5
Change in Working Capital
(1 176)
202
(379)
548
(683)
185
(532)
35
(214)
(258)
584
(940)
(1 622)
(1 362)
(1 108)
218
645
(615)
(2 223)
(898)
(536)
(940)
(846)
(4 076)
(7 078)
(5 605)
3 378
4 479
2 172
467
204
(983)
(609)
(218)
(16)
Cash from Operating Activities
2 199
N/A
(844)
N/A
(1 448)
-71%
(3 062)
-112%
(1 690)
+45%
(29)
+98%
534
N/A
898
+68%
1 079
+20%
2 047
+90%
3 589
+75%
1 308
-64%
690
-47%
560
-19%
378
-33%
1 932
+411%
2 698
+40%
1 357
-50%
(60)
N/A
1 401
N/A
1 748
+25%
1 595
-9%
3 493
+119%
3 515
+1%
(1 517)
N/A
(2 777)
-83%
(1 596)
+43%
(967)
+39%
(1 993)
-106%
(1 235)
+38%
(307)
+75%
(177)
+42%
362
N/A
167
-54%
815
+388%
Investing Cash Flow
Capital Expenditures
(224)
(5)
(27)
23
(198)
(263)
(181)
(199)
(212)
(233)
(304)
(1 652)
(2 881)
(4 766)
(3 718)
(419)
(112)
(120)
(129)
(394)
(506)
(290)
(220)
(1 185)
(2 225)
(3 451)
(1 600)
(446)
(84)
(42)
(114)
(180)
(187)
(241)
(304)
Other Items
(17)
(9)
134
48
1 027
913
63
59
226
(105)
(317)
90
127
629
1 083
226
39
312
15
(762)
(241)
550
(228)
(307)
(534)
(457)
(22)
(123)
274
1 035
1 280
504
182
666
446
Cash from Investing Activities
(241)
N/A
(14)
+94%
107
N/A
71
-34%
829
+1 069%
650
-22%
(118)
N/A
(140)
-19%
14
N/A
(339)
N/A
(621)
-83%
(1 562)
-152%
(2 755)
-76%
(4 137)
-50%
(2 636)
+36%
(193)
+93%
(72)
+63%
192
N/A
(114)
N/A
(1 156)
-915%
(747)
+35%
260
N/A
(448)
N/A
(1 492)
-233%
(2 760)
-85%
(3 909)
-42%
(1 622)
+59%
(569)
+65%
190
N/A
993
+423%
1 166
+17%
324
-72%
(5)
N/A
425
N/A
142
-67%
Financing Cash Flow
Net Issuance of Common Stock
0
21
31
80
82
69
37
(243)
(240)
89
206
(479)
(497)
162
172
1 390
1 460
221
194
320
179
(765)
(54)
966
222
323
101
0
0
1 425
2 132
753
59
0
0
Net Issuance of Debt
(10)
(2)
(6)
(5)
(17)
(17)
(17)
(17)
(18)
(18)
(18)
(17)
(15)
986
(14)
(1 015)
(15)
(16)
(16)
(17)
(18)
(23)
(28)
(33)
(26)
3 958
4 641
165
(967)
(1 080)
(586)
(598)
(1 234)
(1 301)
(1 226)
Cash Paid for Dividends
(21)
(75)
(105)
(105)
(126)
(63)
(63)
(194)
(194)
(191)
(191)
(324)
(325)
(320)
(320)
(196)
(196)
(283)
(283)
(356)
(499)
(501)
(499)
(712)
(846)
(1 626)
(782)
(2)
0
0
(1)
(2)
(1)
0
0
Other
0
0
0
0
0
0
19
0
0
0
23
0
0
38
26
0
0
0
31
0
0
(0)
0
(0)
(0)
0
(1)
(10)
(30)
(14)
(6)
(3)
(5)
0
(1)
Cash from Financing Activities
(32)
N/A
(55)
-74%
(80)
-45%
(29)
+64%
(62)
-111%
(11)
+82%
(24)
-117%
(435)
-1 692%
(452)
-4%
(120)
+74%
20
N/A
(797)
N/A
(825)
-4%
865
N/A
(136)
N/A
179
N/A
1 249
+597%
(77)
N/A
(74)
+4%
(22)
+71%
(338)
-1 466%
(1 289)
-281%
(581)
+55%
220
N/A
(649)
N/A
2 656
N/A
3 959
+49%
153
-96%
(997)
N/A
331
N/A
1 539
+365%
150
-90%
(1 181)
N/A
(1 303)
-10%
(1 227)
+6%
Change in Cash
Effect of Foreign Exchange Rates
(46)
(18)
(51)
(50)
(59)
(33)
(11)
(4)
39
80
100
42
106
110
(48)
(167)
(68)
34
(8)
9
(18)
(35)
(10)
6
(22)
36
82
111
76
42
49
109
112
(66)
(5)
Net Change in Cash
1 880
N/A
(931)
N/A
(1 472)
-58%
(3 070)
-109%
(982)
+68%
576
N/A
381
-34%
318
-17%
679
+114%
1 669
+146%
3 089
+85%
(1 010)
N/A
(2 784)
-176%
(2 602)
+7%
(2 442)
+6%
1 750
N/A
3 806
+117%
1 506
-60%
(255)
N/A
233
N/A
645
+177%
531
-18%
2 453
+362%
2 249
-8%
(4 948)
N/A
(3 994)
+19%
823
N/A
(1 272)
N/A
(2 724)
-114%
131
N/A
2 447
+1 768%
406
-83%
(712)
N/A
(777)
-9%
(275)
+65%
Free Cash Flow
Free Cash Flow
1 975
N/A
(849)
N/A
(1 475)
-74%
(3 039)
-106%
(1 888)
+38%
(292)
+85%
353
N/A
699
+98%
867
+24%
1 814
+109%
3 286
+81%
(345)
N/A
(2 191)
-536%
(4 207)
-92%
(3 341)
+21%
1 513
N/A
2 586
+71%
1 237
-52%
(188)
N/A
1 007
N/A
1 243
+23%
1 306
+5%
3 273
+151%
2 330
-29%
(3 742)
N/A
(6 228)
-66%
(3 196)
+49%
(1 413)
+56%
(2 077)
-47%
(1 277)
+39%
(421)
+67%
(357)
+15%
175
N/A
(74)
N/A
511
N/A

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Follow us
Join more than 320,300+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.